What MNX Global Logistics does

MNX Global Logistics was a US-based, private specialized expedited transportation and logistics provider founded in 1983 and headquartered in Irvine, United States, with 501–1000 employees. The company delivered precision logistics services to pharmaceutical, biotechnology, and healthcare customers, spanning health chain orchestration (drug storage and distribution), advanced therapy logistics (cell and gene therapies, biologics), connected medical device logistics, patient-driven services for decentralized clinical trials, laboratory specimen transport, complex secure logistics for controlled substances and radiopharmaceuticals, and clinical trial packaging. Operations were supported by a proprietary technology stack — Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking and tracking), Marken Maestro™ (clinical trial inventory and order management), Marken Solo™ (client portal), MxWeb and NetShip (client booking platforms), and Polar Track (temperature-monitored tracking) — combined with validated processes and regulatory oversight to meet healthcare and pharmaceutical compliance requirements.

The business model is enterprise B2B with quote-based pricing for specialized logistics services. Revenue is generated through service fees for temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies, billed as professional services rather than transactional shipment fees. Distribution is direct, via enterprise field sales, account managers, and customer service specialists, with engagement channels including phone (+1-800-627-5361), online inquiry forms, and a multilingual (English, German, French, Spanish, Portuguese, Korean, Japanese, Chinese) website presence. The customer base is concentrated in two primary verticals — pharmaceutical and biotechnology companies — with healthcare providers and the home healthcare sector as secondary segments. Historically, MNX pursued inorganic growth, completing four acquisitions between 2016 and 2019 (Aero Express Logistics, Logical Freight Solutions, Network Global Logistics, and Global First) to extend aviation freight and global specialty logistics capabilities.

MNX has been acquired by Marken, a subsidiary of UPS, and the MNX brand has been retired; operations now continue as Marken, UPS Healthcare Precision Logistics. The integration brings MNX's expertise in radiopharmaceuticals, aviation, and complex secure logistics under the larger UPS Healthcare umbrella alongside Polar Speed's in-network pharmacy services. As an independent entity MNX is no longer operating under its original brand; standalone financials are no longer reported, and growth signals now flow through the parent Marken/UPS Healthcare platform.

Name

MNX Global Logistics

Legal name

MNX Global Logistics

Website

https://mnx.com

Company type

Private

Founded year

1983

Operating status

Acquired

Headcount range

501–1,000 employees

Short description

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provided specialized expedited transportation and logistics services — temperature-controlled transport, clinical trial logistics, advanced therapy handling, and complex secure logistics for radiopharmaceuticals — to pharmaceutical, biotechnology, and healthcare customers globally using a proprietary technology stack and validated, regulatory-compliant processes.

Ownership category

akta.pro rank

Product category

Healthcare Logistics Services

NAICS

Freight Transportation Arrangement (488510), Couriers and Express Delivery Services (492110), Refrigerated Warehousing and Storage (493120), Specialized Freight Trucking (4842)

SIC

Arrangement Of Transportation Of Freight & Cargo (4731), Public Warehousing & Storage (4220), Trucking (No Local) (4213)

akta.pro primary industry

Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns) (HLAGAMAC)

akta.pro secondary industries

Clinical Trials & Investigational Product (IP) Cold Delivery (TLAAAJAE), Biologics, Vaccines & Specialty Pharma Ultra-Cold Delivery (TLAAAJAD), Pharmaceutical Cold-Chain Delivery (2–8°C / CRT) (TLAAAJAC), Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI)

Keywords

• Healthcare logistics services
• Cold chain transport
• Clinical trial logistics
• Pharmaceutical distribution
• Temperature-controlled shipping

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D

Revenue model

1. Healthcare Logistics Services: MNX (now Marken) generates revenue through providing specialized logistics services to pharmaceutical and biotech companies. Services include temperature-controlled transport, clinical trial logistics, patient-driven services, and complex secure logistics for radiopharmaceuticals and advanced therapies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

MNX Global Logistics (now Marken, UPS Healthcare Precision Logistics) provides specialized, expedited transportation and logistics services for pharmaceutical, biotechnology, and healthcare clients. Its offering spans temperature-controlled cold chain transport, clinical trial material logistics, advanced therapy logistics for cell and gene therapies, direct-to-patient services, complex secure logistics for radiopharmaceuticals, and end-to-end drug storage and distribution from manufacturing to patient delivery.

Product overview

Marken, UPS Healthcare Precision Logistics (formerly MNX Global Logistics) operates as a unified platform-plus-modules architecture providing end-to-end healthcare logistics services. The portfolio comprises nine core service lines—Health Chain Orchestration, Advanced Therapy Logistics, Connected Medical Device Logistics & Management, Patient Driven Services, Laboratory Advantage, Complex Secure Logistics, Packaging as a Service, Technology & Visibility, and Polar Speed Services—supported by six technology platforms: Marken Apollo™ (warehouse management), Marken FastTrack™ (expedited shipment booking), Marken Maestro™ (inventory management), Marken Solo™ (client portal), MxWeb (web-based client portal), NetShip (online shipping), and Polar Track (temperature-monitored tracking). The platform leverages validated processes, regulatory oversight, and global network infrastructure to serve pharmaceutical, biotechnology, and healthcare clients across all phases from manufacturing to patient delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Chain Orchestration End-to-end drug storage and distribution service managing the complete healthcare supply chain from manufacturing to patient delivery for pharmaceutical clients.
• Advanced Therapy Logistics Specialized logistics for complex biologics, cell therapies, and gene therapies requiring precise temperature control and chain of custody, targeting biotechnology and pharmaceutical clients.
• Connected Medical Device Logistics & Management Integrated logistics and management solutions for medical devices with tracking and visibility throughout the distribution process, serving medical device manufacturers.
• Patient Driven Services Decentralized clinical trial services that deliver investigational drugs directly to patients, supporting home healthcare and distributed trial models for clinical trial sponsors and home healthcare providers.
• Laboratory Advantage Specialized laboratory logistics services including specimen transport, bio-specimen handling, and sample management for clinical and research laboratories.
• Complex Secure Logistics High-security logistics for controlled substances, radiopharmaceuticals, and other sensitive materials requiring enhanced chain of custody, serving pharmaceutical and biotech clients.
• Packaging as a Service Clinical trial packaging services providing temperature-controlled packaging solutions for pharmaceutical shipments.
• Polar Speed Services In-network pharmacy services that strengthen the patient-driven services portfolio, providing temperature-controlled medication delivery for home healthcare and clinical trial patients.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• UPS HealthcarecoreOEM/ Whitelabel/ Licensing PartnerMNX Global Logistics has been acquired by UPS Healthcare and now operates under the Marken brand as 'Marken, UPS Healthcare Precision Logistics'. The acquisition brought MNX's specialized expertise in radiopharmaceuticals, aviation, and complex secure logistics under the UPS Healthcare umbrella, combining decades of experience with UPS's global infrastructure and technology investments.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• World Courier: World Courier (an AmerisourceBergen company) is the leading specialty pharma and clinical trial logistics provider globally, offering temperature-controlled transport, advanced therapy logistics, and direct-to-patient services—directly overlapping MNX/Marken's core offering.
• Biocair: Biocair is a specialist life sciences logistics provider focused on temperature-controlled pharma, clinical trial, and advanced therapy shipments across global lanes, directly comparable to MNX's specialty courier offering.
• QuickSTAT: QuickSTAT specializes in global clinical trial logistics, biopharmaceutical courier services, and direct-to-patient delivery—directly competing with MNX/Marken in investigator-site and patient-centric services.
• DHL Medical Express: DHL Medical Express provides global time-critical, temperature-controlled pharmaceutical shipments with comparable GxP/GDP compliance, serving the same enterprise pharma and biotech customer base as MNX/Marken.

Broad incumbents

• Cardinal Health 3PL Services: Cardinal Health's third-party logistics services include medical product distribution, cold-chain storage, and pharmaceutical supply chain management—overlapping with MNX/Marken's health chain orchestration and medical device logistics offerings.
• FedEx Custom Critical: FedEx Custom Critical provides time-critical, temperature-sensitive, and high-value shipment services including pharma and healthcare—overlapping with MNX's expedited and radiopharmaceutical services as part of a broader logistics portfolio.
• DHL Supply Chain Life Sciences: DHL Supply Chain's Life Sciences division provides contract logistics, warehousing, and transportation for pharma and medical devices—overlapping with MNX/Marken's warehousing and health chain orchestration services.
• Yusen Logistics (Healthcare): Yusen Logistics provides GDP-compliant healthcare logistics including temperature-controlled transport, warehousing, and clinical trial distribution across Asia, Europe, and the Americas—competing with MNX/Marken on global pharma lanes.
• Kuehne+Nagel Life Sciences & Healthcare: Kuehne+Nagel's Life Sciences & Healthcare division offers GxP-compliant pharma logistics, cold chain, and clinical trial services globally—competing with MNX/Marken across multiple service lines with broader scale.

Emerging players

• Cryoport Systems: Cryoport provides integrated temperature-controlled supply chain solutions for the life sciences industry with strong focus on regenerative medicine, cell and gene therapies—directly competing with MNX/Marken's advanced therapy logistics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/mnxlogistics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MNX Global Logistics